Literature DB >> 3899156

A new monoclonal antibody to epithelial membrane antigen (EMA)-E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2.

E Heyderman, I Strudley, G Powell, T C Richardson, J L Cordell, D Y Mason.   

Abstract

Two polyclonal rabbit antibodies to epithelial membrane antigen (EMA), two mouse monoclonal antibodies (E29 and HMFG-2), and a "cocktail" of these two monoclonals have been compared using an indirect immunoperoxidase technique. Sections from 25 tissues (17 malignant and 8 benign), were examined. The distribution of staining with each of these reagents was similar, but the polyclonal antibodies produced stronger staining in colorectal carcinomas and lactating breast, whereas staining with the monoclonal antibodies was stronger in non-neoplastic pleural mesothelium and in pulmonary alveolar cells. When the two monoclonals were mixed there was no increase in staining intensity. E29 gave a "cleaner" result than HMFG-2, with better discrimination between cells and stroma, and is highly suitable for routine diagnostic histopathology.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899156      PMCID: PMC1977186          DOI: 10.1038/bjc.1985.201

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

3.  Adsorbents for affinity chromatography. Use of N-hydroxysuccinimide esters of agarose.

Authors:  P Cuatrecasas; I Parikh
Journal:  Biochemistry       Date:  1972-06-06       Impact factor: 3.162

4.  Proteins and glycoproteins of the milk fat globule membrane.

Authors:  D Kobylka; K L Carraway
Journal:  Biochim Biophys Acta       Date:  1972-11-02

5.  Detection of micrometastases in patients with primary breast cancer.

Authors:  W H Redding; R C Coombes; P Monaghan; H M Clink; S F Imrie; D P Dearnaley; M G Ormerod; J P Sloane; J C Gazet; T J Powles
Journal:  Lancet       Date:  1983-12-03       Impact factor: 79.321

6.  Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms.

Authors:  G Delsol; K C Gatter; H Stein; W N Erber; K A Pulford; K Zinne; D Y Mason
Journal:  Lancet       Date:  1984-11-17       Impact factor: 79.321

7.  Intercellular canaliculi in eccrine sweat glands: an immunoperoxidase study.

Authors:  R M Graham; P H McKee; D V Chapman; T C Richardson; M R Stokoe; E Heyderman
Journal:  Br J Dermatol       Date:  1985-04       Impact factor: 9.302

8.  Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.

Authors:  E Heyderman; B M Brown; T C Richardson
Journal:  J Clin Pathol       Date:  1984-12       Impact factor: 3.411

9.  Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry.

Authors:  J Cordell; T C Richardson; K A Pulford; A K Ghosh; K C Gatter; E Heyderman; D Y Mason
Journal:  Br J Cancer       Date:  1985-09       Impact factor: 7.640

10.  Epithelial membrane antigen: partial purification, assay and properties.

Authors:  M G Ormerod; K Steele; J H Westwood; M N Mazzini
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

View more
  26 in total

1.  Cell line provenance.

Authors:  R Ian Freshney
Journal:  Cytotechnology       Date:  2002-07       Impact factor: 2.058

2.  Immunohistochemical observations of keratins, involucrin, and epithelial membrane antigen in urinary bladder carcinomas from patients infected with Schistosoma haematobium.

Authors:  S Fukushima; N Ito; M N el-Bolkainy; H N Tawfik; Y Tatemoto; M Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Use of immunocytochemical staining to identify cells in peritoneal fluid and washings at laparoscopy and laparotomy.

Authors:  A K Ghosh; A I Spriggs; M Charnock
Journal:  J Clin Pathol       Date:  1986-12       Impact factor: 3.411

4.  A high concentration of Merkel cells in the bulge prior to the attachment of the arrector pili muscle and the formation of the perifollicular nerve plexus in human fetal skin.

Authors:  Y Narisawa; K Hashimoto; Y Nakamura; H Kohda
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

5.  Critical evaluation of monoclonal antibody staining in breast carcinoma.

Authors:  D M Parham; G Coghill; A J Robertson
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

6.  Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2.

Authors:  E Heyderman; S E Larkin; P J O'Donnell; A M Haines; P J Warren; A Northeast; A G Grant
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

7.  Choroid plexus papillomas: consideration of a surgical series of 33 cases.

Authors:  L Tacconi; R Delfini; G Cantore
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

8.  Immunohistochemical characterization of undifferentiated carcinomas of the ovary.

Authors:  Y Kuwashima; T Uehara; K Kishi; K Shiromizu; M Matsuzawa; S Takayama
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

9.  KL-6 is another useful marker in assessing a micropapillary pattern in carcinomas of the breast and urinary bladder, but not the colon.

Authors:  Yuji Ohtsuki; Naoto Kuroda; Tatsuo Umeoka; Ryohei Watanabe; Kenji Ochi; Yuhei Okada; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2009-06-18       Impact factor: 2.309

10.  Malignant choroid plexus papilloma of the IV ventricle.

Authors:  H Imaya; M Kudo
Journal:  Childs Nerv Syst       Date:  1991-04       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.